Phibro Animal Health Corp (PAHC): Free Cash Flow
$9.87M
Year ended 2026-06-30
-12.3%
5-year compound annual growth
+27.5%
10-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $9.87M | -76.4% | 2026-08-26, From 2025-07-01 |
| 2025-06-30 | $41.83M | -9.8% | 2026-08-26, From 2024-07-01 |
| 2024-06-30 | $46.36M | n/m | 2026-08-26, From 2023-07-01 |
| 2023-06-30 | -$38.48M | n/m | 2025-08-27, From 2022-07-01 |
| 2022-06-30 | -$5.39M | n/m | 2024-08-28, From 2021-07-01 |
| 2021-06-30 | $18.99M | -25.0% | 2023-08-30, From 2020-07-01 |
| 2020-06-30 | $25.30M | +46.4% | 2022-08-24, From 2019-07-01 |
| 2019-06-30 | $17.28M | -66.4% | 2021-08-25, From 2018-07-01 |
| 2018-06-30 | $51.46M | -33.6% | 2020-08-26, From 2017-07-01 |
| 2017-06-30 | $77.50M | n/m | 2019-08-27, From 2016-07-01 |
| 2016-06-30 | $866.0K | -98.2% | 2018-08-27, From 2015-07-01 |
| 2015-06-30 | $48.65M | n/m | 2017-08-30, From 2014-07-01 |
| 2014-06-30 | -$20.56M | n/m | 2016-08-29, From 2013-07-01 |
| 2013-06-30 | -$18.51M | n/m | 2015-09-10, From 2012-07-01 |
| 2012-06-30 | $17.16M | n/a | 2014-09-18, From 2011-07-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $9.87M | -76.4% |
| Alkermes plc. (ALKS) | 2025-12-31 | $480.33M | +18.4% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $702.34M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$93.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $246.45M | +1.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $105.15M | -33.1% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$307.45M | n/m |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$190.02M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$320.03M | n/m |
Compare PAHC, ALKS, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗